Osteoporosis drug may have hidden benefits for muscles and diabetes
NCT ID NCT07271771
Summary
This study is testing if denosumab, a common osteoporosis medication, can also improve muscle strength and how the body processes sugar (insulin sensitivity) in postmenopausal women with type 2 diabetes. It will involve 40 participants who will receive either the real drug or a placebo for one year. The goal is to see if this treatment offers benefits beyond just bone health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.